NasdaqGS - Nasdaq Real Time Price USD
Gossamer Bio, Inc. (GOSS)
1.0950
+0.0050
+(0.46%)
At close: May 7 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -0.19 | -0.19 | -0.72 | -0.44 |
| Low Estimate | -0.22 | -0.23 | -0.94 | -0.81 |
| High Estimate | -0.17 | -0.17 | -0.64 | -0.12 |
| Year Ago EPS | -0.19 | 0.22 | -0.25 | -0.72 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 3.95M | 4.09M | 19.85M | 54.87M |
| Low Estimate | -- | -- | -- | 16.67M |
| High Estimate | 7.97M | 8.15M | 38.9M | 120.4M |
| Year Ago Sales | -- | 95.84M | 114.7M | 19.85M |
| Sales Growth (year/est) | 0.00% | -95.73% | -82.69% | 176.38% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.19 | 0.27 | -0.14 | -0.17 |
| EPS Actual | -0.19 | 0.22 | -0.14 | -0.15 |
| Difference | 0 | -0.05 | 0 | 0.02 |
| Surprise % | 0.05% | -19.96% | 3.05% | 10.69% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.19 | -0.72 | -0.44 |
| 7 Days Ago | -0.19 | -0.19 | -0.73 | -0.44 |
| 30 Days Ago | -0.19 | -0.19 | -0.73 | -0.44 |
| 60 Days Ago | -0.19 | -0.18 | -0.71 | -0.42 |
| 90 Days Ago | -0.19 | -0.18 | -0.71 | -0.42 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 4 |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GOSS | -0.53% | -185.69% | -188.06% | 38.66% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 4/17/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 3/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/30/2024 |
Related Tickers
STOK Stoke Therapeutics, Inc.
8.66
-1.03%
NUVB Nuvation Bio Inc.
2.0400
-2.39%
HOOK HOOKIPA Pharma Inc.
1.6100
+8.78%
ALEC Alector, Inc.
1.0200
-2.86%
BDTX Black Diamond Therapeutics, Inc.
1.5500
+5.80%
STRO Sutro Biopharma, Inc.
0.9934
+4.56%
INZY Inozyme Pharma, Inc.
1.3300
+5.56%
RLAY Relay Therapeutics, Inc.
2.9500
-6.35%
PASG Passage Bio, Inc.
0.3425
+1.30%
SGMO Sangamo Therapeutics, Inc.
0.6504
+6.27%